Description
Overview
ASN Breakthroughs and Challenges of a New Era in ADPKD provides an in-depth exploration of the latest advancements and ongoing challenges in Autosomal Dominant Polycystic Kidney Disease (ADPKD) care. This comprehensive resource addresses critical aspects such as risk stratification, diagnostic technologies, therapeutic management, and emerging clinical approaches.
The book delves into the complexities of ADPKD across the patient lifespan, including childhood management and the transition to adult care, while highlighting disparities in treatment access and the evolving landscape of FDA approvals. It is an essential guide for navigating the multifaceted issues facing patients and healthcare providers in this rapidly advancing field.
Key Topics Covered
- Utilization challenges in ADPKD care during the 2020s
- Mutation-centric approaches to ADPKD risk stratification
- Application and interpretation of 3D kidney volumetrics for clinical decision-making
- Challenges associated with renal replacement therapy (RRT) in ADPKD patients
- Management strategies for childhood PKD and transitioning to adult nephrology care
- Diagnosis through low-cost sequencing platforms to enhance accessibility
- Distinctions in care between PKD and other chronic kidney diseases (CKD)
- Emerging metabolic targeting therapies for ADPKD
- Addressing health disparities in ADPKD care delivery
- Navigating hurdles in FDA approval processes including novel clinical studies
- Managing patient expectations and longstanding clinical challenges
- Clinical recommendations for addressing brain aneurysms in ADPKD patients
- Approaches to the management of liver cysts associated with ADPKD
This detailed coverage ensures readers are well-informed about both the scientific advancements and practical clinical considerations impacting ADPKD treatment today.
Who This Book Is For
This book is designed for nephrologists, clinical researchers, and healthcare professionals engaged in kidney disease care who seek to deepen their understanding of ADPKD. It is also useful for medical educators and trainees requiring a current synthesis of breakthroughs and clinical challenges in this area.
Additionally, healthcare policymakers and pharmaceutical scientists interested in FDA regulatory pathways and new therapeutic targets for kidney disease will find valuable insights within its pages.
- Nephrologists and kidney disease specialists
- Clinical researchers in nephrology and genetics
- Medical educators and trainees in kidney health fields
- Healthcare policymakers focused on CKD and rare diseases
- Pharmaceutical and biotech professionals developing ADPKD therapies
Why Add This Book To Your Library
ASN Breakthroughs and Challenges of a New Era in ADPKD offers a unique consolidation of current knowledge and clinical practice challenges in one authoritative volume. It bridges translational research with practical care strategies, making it an indispensable resource.
Its focus on emerging diagnostic technologies, risk stratification techniques, and novel therapeutic avenues ensures readers are equipped to apply the latest evidence-based care models. The book’s attention to health disparities and patient-centered challenges further enriches its relevance to real-world clinical scenarios.
- Comprehensive synthesis of current ADPKD research and clinical practice
- Guidance on cutting-edge diagnostic and prognostic tools
- In-depth discussion of therapeutic challenges including RRT and metabolic targeting
- Insights into regulatory and approval processes impacting treatment availability
- Focus on health equity and multidisciplinary care approaches
Access & Format
This book is available through the American Society of Nephrology (ASN) platform, providing easy online access for healthcare professionals and researchers globally. The content is designed to support digital reading and integration with clinical reference tools.
Readers can expect detailed chapters rich in evidence-based guidance and extensive expert commentary, supporting both clinical practice and academic study in ADPKD.
